Melanoma Treatment Market by Treatment, Class of Drugs, Distribution Channel and Geography. Key Players are Hoffmann-La Roche Ltd, Bristol-Myers Squibb, Novartis, Genetech, AstraZeneca, Polynoma, Sanofi, Amgen, Takeda and Merck.

Precision Business Insights (PBI) in its report titled “Melanoma Treatment Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2018 and Forecast 2019-2025” assesses the market performance over seven years forecast period from 2019 to 2025. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the melanoma treatment market revenue growth over forecast period.

The melanoma treatment market size was accounted for US$ XX Mn in 2018 and anticipated to account for US$ XX Mn by 2025. Increased prevalence of cancer which develop in the cells of the skin called melanocytes that produces melanin will create a demand for melanoma treatment market.

Melanoma treatment market segmented on the basis of treatment, class of drug and distribution channel.

Targeted Therapy Expected to Dominate the Market

Based on treatment the market is segmented into targeted therapy, biological therapy, chemotherapy and radiation therapy. Targeted therapy is anticipated to grow at a highest CAGR of about XX% owing to benefits such as limited adverse effects and higher efficiency of targeted therapy drugs. Advancements in genomics have led to development of targeted cancer therapies for treatment of patients who are incurable by intensive cytotoxic chemotherapy. Radiation therapy segment is expected to exhibit steady growth over the forecast period owing to increasing number of advanced melanoma cases and use of radiation as an adjuvant therapy post-surgery. Radiation therapy is rarely used as primary treatment. It is only administered to patients in stage 4, who cannot be treated with surgery.

Hospital Pharmacies Will Dominate the Revenue Share.

Based on distribution channel, melanoma treatment market segmented into hospital pharmacies, retail pharmacies and online pharmacies. The hospital pharmacies are witnessed to account for major revenue share over the forecast period due to advancement in the technology and increased research in the treatment of the cancer.

Read more Insights at https://www.precisionbusinessinsights.com/market-reports/melanoma-treatment-market/

North America, Accounts for Major Revenue Share for Melanoma Treatment Market

Precision Business Insights (PBI), melanoma treatment market report analyses the market in different regions North America, Europe, Asia Pacific, Latin America and Middle East and Africa. According to regional analysis, North America accounted for major revenue share due to high prevalence of disease in the region.

Europe melanoma treatment market projected to grow at notable rates owing to the factors such as growing prevalence of melanoma, presence of key market players in the region and increase in R&D towards the development of new treatments for cancer backed with growing government funding. Asia Pacific melanoma treatment market projected to have the lucrative growth opportunity due to growing healthcare expenditure by the population and increase in R&D investments by the companies and government in the region.


Launch of New Drug Play Vital Role in Melanoma Treatment Market

Market strategy such as launch of new product will play an important role in the development of the market. For instance, in September 2017 Merck Sharp & Dohme launched its blockbuster drug Keytruda in India for the treatment of unresectable or metastatic melanoma.

Download free Sample Report at https://bit.ly/2DcKKL9

Key players in the market include Hoffmann-La Roche Ltd. (Switzerland), Bristol-Myers Squibb (U.S.), Novartis AG (Switzerland), Genetech Inc. (U.S.), AstraZeneca plc (U.K.), Polynoma LLC (CK Life Sciences) (Hong Kong), Sanofi S.A. (France), Amgen Inc. (U.S.), Takeda Pharmaceutical Company (Japan), Merck & Co. Inc. (U.S.).

Detailed Segmentation

By Treatment

o Targeted Therapy
o Chemotherapy
o Radiation Therapy
o Biological Therapy

By Class of Drug

o MEK Inhibitors
o Monoclonal Antibodies
o BRAF Inhibitors
o Others

By Distribution Channel

o Hospital Pharmacies
o Retail Pharmacies
o Online Pharmacies

Geography

o North America
 U.S.
 Canada
o Europe
 Germany
 UK
 France
 Russia
 Spain
 Italy
 Rest of Europe
o Asia-Pacific
 China
 Japan
 India
 ASEAN
 Rest of Asia Pacific
o Latin America
 Brazil
 Mexico
 Argentina
 Chile
 Rest of Latin America
o Middle East and Africa
 South Africa
 Gulf Corporation Council Countries(GCCC)
 Rest of MEA

About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact us
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US):+1-866-598-1553
Website @https://www.precisionbusinessinsights.com

This release was published on openPR.